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Abstract
To integrate heterogeneous and large omics data constitutes not only a conceptual challenge but a practical
hurdle in the daily analysis of omics data. With the rise of novel omics technologies and through large-scale
consortia projects, biological systems are being further investigated at an unprecedented scale generating
heterogeneous and often large data sets. These data-sets encourage researchers to develop novel data integration
methodologies. In this introduction we review the definition and characterize current efforts on data integration in
the life sciences. We have used a web-survey to assess current research projects on data-integration to tap into the
views, needs and challenges as currently perceived by parts of the research community.
Introduction
Data integration is now a very commonly used notion in
life sciences research. As of 2006 there were 1,062 papers
explicitly mentioning “data integration” in their abstract
or title, whereas this number has more than doubled in
2013 (2,365). However, there is still no unified definition
of data integration, nor taxonomy for data-integration
methodologies despite some recent efforts on this topic
[1-5]. In February 2013, the FP7 STATegra project
(http://stategra.eu/) and the COST Action SeqAhead
(http://seqahead.eu/), two EU-funded initiatives on the
bioinformatics of high-throughput data, organized in the
city of Barcelona the “Workshop of Omics and Data Inte-
gration”, with the aim of reviewing current technologies
on omics data production and the available methods for
their integrative analysis. The workshop consisted of con-
tributed talks, sessions for open discussion and we
included an on-line survey to investigate the current opi-
nions of the research community on this topic. Three
major conclusions were extracted from the Barcelona
workshop. First, there is a clear need for revisiting the
concepts of data integration and stating available
resources in this field; second, it was advantageous to
extend our survey to a broader audience of scientists in
life sciences, and third the commitment of organizers to
publish the discussed topics, contributions and outcome
of the public survey in a relevant journal is an important
driver to spearhead further discussion in the community.
In this supplement we discuss these three conclusions in
some detail. In this introductory article we review current
definitions of data integration and describes it formally as
the combination of two challenges: data discovery and
data exploitation [5]. We briefly list major public efforts
in creating resources (datasets, methods and workshops)
for data integration. We also present the results of the
extended community survey, which took place between
February and March 2013 and on the basis of the survey
we extract a couple of conclusions which warrant further
elaboration in the community. Finally we introduce the
contributions of the papers collected in this supplement
within the context of the discussed data integration
topics and stated community needs.
Challenges of data integration in life sciences
Research in life sciences has the generic goal to identify
the components that make up a living system (G1) and
to understand the interactions among them that result in
the (dys)functioning of the system (G2). Collection of
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biological data is therefore a method to catalogue the ele-
ments of life, but the understanding of a system requires
the integration of these data under mathematical and
relational models that can describe mechanistically the
relationships between their components. We can illus-
trate the state of affairs on data integration in life science
research using a simple example taken from metabolic
modeling. Let us consider the glycolysis pathway (GLY),
which consists of the conversion of glucose into pyruvate
to release energy (see Figure 1 and [7]). In the study of
GLY, G1 is considered “to be known” as there are a
detailed set of genes, proteins and metabolites already
described; however we are not yet certain that this list
contains all involved elements, for example the list does
not incorporate the epigenetic marks that may be asso-
ciated to the regulation of GLY. When we consider G2,
Figure 1 again depicts the current knowledge of the sys-
tem and may erroneously imply that the system - defined
as a set of interactions - is fully known. However, path-
way elements and relations may be missing (see for
instance the recent work on synthetic non-oxidative gly-
colysis [7]) and this representation does not allow us to
determine completeness. Once more, the figure does not
depict all the regulatory mechanisms involved or the
rates of the reactions. This brings us to the first question
of: “What are the available data that can be used to fully
characterize the GLY metabolic pathway?”
The present situation is very fortunate since over the
last decades several different types of data were gener-
ated and huge efforts were dedicated to create database
repositories for different data-types where investigators
were encouraged to deposit and share datasets asso-
ciated with scientific publications. The benefits of this
are twofold: on the one hand it enables or support
researchers in reproducing and validating the analysis of
other labs, and on the other hand it allows researchers
to analyze data in novel ways and/or with different
methodologies that were not originally considered by
the team who generated the data. To illustrate this we
investigated the availability of GLY-related datasets in
Gene Expression Omnibus (GEO [8,9]) as an example of
a major gene expression data repository and we readily
made two observations. There exist a small number of
datasets pertaining to the direct investigation of the
GLY pathway, but the majority of microarray and NGS
datasets contain information about the GLY pathway at
the mRNA level. Moreover, it is possible to complement
such information with enzyme kinetics data from data-
bases such as BRENDA [10]. These observations bring
us to the next questions. Once relevant data sources
have been identified, “How do we integrate all (or part
of) the available datasets in order to improve our defini-
tion of the GLY system?” and “How do we re-use all this
information when designing new and novel experiments?”
All the above questions and challenges intuitively
define the notion of “data integration“.
Data integration challenges
The term data integration refers to the situation where,
for a given system, multiple sources (and possible types) of
data are available and we want to study them integratively
to improve knowledge discovery. In the GLY example
Figure 1 Glycolysis. Description of the ten reactions and their associated enzymes of the metabolic pathway (reproduced from http://en.
wikipedia.org/wiki/File:Glycolysis2.svg).
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system we could have two datasets describing the system,
one containing information about gene expression at the
mRNA level and the other describing the CpG DNA
methylation profile. In several studies [11,12] where gene
expression and DNA methylation data were available, the
genome-wide relationships between DNA methylation and
gene expression have been investigated in order to infer
generic rules to questions such as: “Does DNA methylation
regulation occurs at CpG islands and/or shores?”, or “How
does DNA methylation in promoters/gene-bodies/enhan-
cers regulate gene expression?” [13]. These kinds of ana-
lyses have advanced our understanding of gene regulation
by providing “generic rules yet with several exceptions”
that associate epigenetic modifications with transcription
[11,12]. For instance, as a general rule CpG methylation in
promoters in mammals was found to be anti-correlated
with gene expression, while CpG methylation in gene
bodies in mammals was positively correlated; yet these
generic rules are observed as a trend, but are not necessa-
rily true for all genes and/or for all biological situations.
To understand the challenges of data integration it is
first required to define the term. The term “data integra-
tion“ first appeared from the need to access different data-
bases with overlapping content to provide “a redundancy
free representation of information from a collection of data
sources with overlapping content” [14] which describes a
need that appeared when the first databases were designed
[15] and it was required to connect several of them: “inte-
gration of multiple information systems aims at combining
selected systems so that they form a unified new whole and
give users the illusion of interacting with one single infor-
mation system”. The aims of database integration were
to make data more comprehensively available, and to
increase the value of existing data by allowing previously
difficult queries to be made upon it. Data mining (as a
step in Knowledge Discovery in Databases [16,17]) is a
major beneficiary from database integration. However this
definition considers only access to data, and not exploita-
tion of data, hence this definition of data integration is not
fully applicable to life sciences research.
We define data integration as the use of multiple
sources of information (or data) to provide a better under-
standing of a system/situation/association/etc; hence data
integration, as defined here, is an action performed on a
daily basis by most individuals, and a critical element in
research.
Data integration in the life sciences becomes a more
complex challenge considering the current “data explo-
sion”. This “added” challenge has been already been duly
recognized; for instance in 2010 the National Research
Council of the National Academies in US organized a
workshop to “explore alternative visions for achieving
large-scale data integration in fields of importance to the
federal government” [5]. The workshop’s aims and main
results were reported in [5]; at the beginning of the docu-
ment two main challenges associated with data integration
were defined: data discovery and data exploitation. We
followed the same structure in the present review and
the next sub-sections briefly detail these challenges in the
life sciences.
Data discovery
Data source discovery is defined as the identification of
relevant data sources. Discovery of publicly available bio-
logical data sources is easy (“just google it” albeit with
some exceptions, e.g. neuroscience [18]), whereas disco-
vering the “appropriate data” is a more complicated task.
One problem is the diversity of existing data types and
formats, each one compliant to a different standard,
which results in data heterogeneity and what has been
called a “loose federation of bio-nations” [2]. The publica-
tion of specialized web databases has flourished in the
last decade due to the relative ease of creation and main-
tenance and the reputation that it brings to the develo-
pers [2]. While specialized platforms may answer specific
needs of the research community they may also intro-
duce biases that affect data analysis. Two examples of
this problem are the pathways and miRNA databases.
The early 2000s witnessed the beginning of the genera-
tion of many pathway databases and their number has
been increasing ever since, but has stabilized in the 2010s
[2,4]. By 2013, Pathguide [19] reported a list of 547 biolo-
gical pathways and molecular interaction related
resources. These resources are not simply complemen-
tary, but often define similar signaling and metabolic
pathways with different boundaries and components.
This different specification is not irrelevant as many gen-
ome analysis methods are based on pathways and are
therefore affected by how these are defined (see for
instance [20] in this supplement). A second example
relates to the storage of miRNA information [21]; this
field has observed the development of generic purpose
databases (e.g. miRBase and miRNAmap), many specia-
lized databases (e.g. miRWalk, mirDB and Tarbase
among others), and even standards for miRNA annota-
tion [22]. In order to cope with this heterogeneity addi-
tional resources were developed such as catalogs of all
available resources (e.g. Pathguide in pathways) and
novel and larger databases developed in a joint effort
between the developers of many older miRNA databases
(see for instance RNAcentral [22]). We foresee two possi-
ble future scenarios: in the first one developers of novel
data-type resources, learning from previous experiences,
will join efforts to consolidate data and create standards
at earlier stages; in the second one we will accept redun-
dant overlaps and solve them with data integration and
knowledge management approaches.
The rise of database resources certainly helps but does
not solve entirely the problem of easy access to relevant
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data. An example is the Gene Expression Ombinus (GEO
[8,9]); GEO (similarly to ArrayExpress [23]) is a data
repository for microarray and NGS data that requires the
data producers to submit data following the Minimum
Information About a Microarray Experiment (MIAME)
guidelines [24]. MIAME was originally designed to pro-
vide standards for microarray data sharing to ensure that
“data can be easily interpreted and that results from its
analysis can be independently verified” [24]; GEO
requires that both raw and normalized data be available,
samples are annotated (including experimental design)
and laboratory and data processing protocols are
described. Enforcing MIAME allowed many researchers
to reexplore datasets from novel perspectives and “more
and more research is now built on the analysis of data
that were not collected by the researchers themselves, and
many of the extant data have not been utilized to their
full potential“ [5]. However, annotation of experimental
data in GEO still makes little use of controlled vocabul-
aries (e.g ontologies), which is necessary for automated
retrieval of relevant datasets for specific large-scale stu-
dies. Therefore finding datasets for a specific condition is
possible, but using all samples associated to that condi-
tion without previous manual curation is still unfeasible.
We consider that the integration of Laboratory Informa-
tion Management systems (LIMS) and/or Experiment
Management Systems (see in this supplement [25]) in lab-
life operations of omics data, and its standardization (such
as the use of ontology-derived nomenclatures) and use in
submission to public data repositories will smooth the
path towards efficient data discovery and sharing.
Data exploitation
Data exploitation refers to the effective use of collective
information to obtain new insights [5]. We can classify
data exploitation according to the type of data used
(similar or heterogeneous data types) or the information
considered (all data points from all studies or summary
results of individual studies, i.e. meta-analysis [26,27]).
However, no classification will fully characterize contem-
porary research as researchers are blurring the bound-
aries by developing hybrid methodologies to optimize
data analysis outcomes. We next develop some examples
in current research.
If we consider datasets of similar data types, meta-
analysis (that is, combining summary information from
independent studies [26,27]) is a widely used statistical
tool, as in many recent GWAS studies [28]. Importantly,
we consider meta-analysis as a sub-type of data integra-
tion methodologies.
Data integration of heterogeneous data types is cur-
rently an active field of research where biostatisticians
are constantly proposing hybrid approaches to improve
data utilization and scientific discovery. Concepts such as
the classification of data as “similar” or “heterogeneous”
are still sometimes an open question [29] which clearly
depends on the specific context. Hamid and collaborators
define data as similar if they are from the “same underly-
ing source“ (e.g. all gene expression) and as heteroge-
neous if at least two fundamentally different data sources
are involved (e.g. SNP and gene expression). Nevertheless
other aspects such as technology may make integration
complex, for example, when integrating RNA-seq and
microarray based mRNA profiling. Following these defi-
nitions, and considering exploitation of datasets with het-
erogeneous data types involved (either across studies or
within studies) then tools such as Co-Inertia Analysis
[30,31], Generalized Singular Value Decomposition [32]
and Integrative Bi-Clustering [33] among others are rele-
vant. A comparison between these three methodologies
in the integrative analysis of mRNA and protein abun-
dance from a study of Plasmodium falciparum is included
in this supplement [34]. In this supplement, Reverter
et al. [35] propose a kernel PCA methodology that first
selects the appropriate kernel for each data type and sec-
ond combines the kernels from the different data types
for a given statistical task.
Moreover, data exploitation in biological research
involves not only actual datasets but also previous
knowledge (sometimes referred to as Biological Domain
Data [29]) which is captured in knowledge databases
such as Gene Ontology [36] or the many biological
pathway databases such as KEGG [37], or Reactome
[38]. Gene Set Enrichment Analysis (GSEA, [39,40]) is a
popular approach for integrating previous biological
knowledge in the analysis of transcriptomics, which has
been extended to other domains such as genomics and
proteomics (e.g. [41] in this supplement) and the analy-
sis of genomic regions (GREAT, [42]). Interestingly
novel methods are still appearing that incorporate the
biological domain knowledge also in the analysis of het-
erogeneous datasets. This supplement reviews the math-
ematical background of different methodologies that
improve the integration of high-throughput transcrip-
tomics and metabolomics data by incorporating prior
knowledge in the form of gene sets and pathways [43].
Brief overview of current approaches to data integration
Data integration is both a challenge and an opportunity
and most certainly an increasing reality in genome
research. Scientists have acknowledged that biological sys-
tems cannot be understood by the analysis of single-type
datasets as the regulation of the system certainly occurs at
many levels (see [29,44] and in this supplement [45]).
Therefore projects have appeared aiming to investigate
biological systems at several levels and create large hetero-
geneous data-sets. In several cases, such efforts ended in
the design of novel methodologies to analyze the data.
Furthermore workshops and conferences focused on the
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topic are starting to proliferate. These three aspects are
detailed below.
Data sources
The Human Genome Project [46,47] is probably the
most well known biological project before 2000, but
during the beginning of 21st century numerous other
even more data-intense biological projects have been
granted research funding. We aim to describe briefly a
few of the most relevant projects, and prioritizing those
where the resulting datasets are (or will be) publicly
available. Other projects of interest not discussed here
include the suite of Phantom Projects [48], TRANSFAC
database [49] or the previously described GEO.
1000 Genomes Project [50,51] aims to identify those
generic genetic variants that have frequencies of at least
1% in the human population by sequencing many indivi-
duals with the novel NGS technologies. The project pre-
sented a technical challenge of how to store and manage
not just the 1000 resulting genomes but the raw and pro-
cessed data associated with them. The 1000 Genome Pro-
ject is not as such a data integration driven project but
certainly provides useful information on the identification
of conserved regions and in GWAS studies.
Encyclopedia of DNA Elements Project (ENCODE,
[52-54]): considering that the genomes of several models
organisms were nearly completed, ENCODE (Homo
Sapiens), modENCODE (C. elegans and D. melanogaster
[44]), and mouseENCODE (Mus musculus [55,56]) pro-
jects were launched with the common goal of identifying
all functional elements within the genome, including
“protein-coding genes, non-protein-coding genes, transcrip-
tional regulatory elements, and sequences that mediate
chromosome structure and dynamics” among them. These
projects represent truly integration-based approaches
which aim to characterize for a set of “animal models and/
or tissues and/or cell lines” the profile of mRNA expres-
sion (e.g. RNA-seq, CAGE), histone marks and transcrip-
tion factor binding profiling (ChIP-seq), DNA methylation
(RRBS), chromatin conformation (e.g. ChIA-PET, 5C) and
the location of active regulatory regions (DNAse-seq)
among others. In September of 2012 the ENCODE con-
sortium launched a synchronized publication effort with
the preliminary analysis of the data.
The Cancer Genome Atlas Project (TGCA): TGCA’s
major aim is to generate insights into the heterogeneity of
different cancer subtypes by creating a map of molecular
alterations for every type of cancer at multiple levels [57].
For instance the endometrial carcinoma has been charac-
terized by mRNA, miRNA, protein, DNA methylation,
copy number alterations and somatic chromosomal aber-
rations [58].
Immunological Genome Project (ImmGen [59]) aims to
characterize the mouse immunological system. ImmGen
used microarrays to profile the mRNA of most immune
cell types under carefully standardized conditions. Interest-
ingly, ImmGen identified the project as a combined effort
between immunologists and computational biologists, and
is intended as a public resource. Not surprisingly, ImmGen
has become a key resource in numerous investigations of
the murine and human immune system research (e.g. [60]).
Method development
Most of the previous data-intensive projects required the
development of novel methodologies to analyze the data.
Within ENCODE there has been a considerable effort to
identify the relationship between combinations of histone
marks and the activity state of DNA elements; Dynamic
Bayesian Networks [61] have been used to classify inter-
vals of the genome of K562 into specific classes (e.g. Pro-
tein Coding Transcription Start Sites) and more recently
self-organizing maps [62] have been used for a similar
purpose. Network analysis have also been addressed at
ENCODE by the investigation of DNase-seq data, which
allows the identification of active regulatory DNA ele-
ments, and its integration with Position Weight Matrixes
to generate regulatory networks for each ENCODE cell-
type [63,64]. To visualize networks circular plots were
generated with Circos [65].
Immgen is the data-intensive project where the most
advanced network inference methodology has been
applied. In [66] authors developed Ontogenet to identify
Transcription Factors (TF) acting as differentiation stage-
specific regulators of mouse hematopoiesis. The metho-
dology first identified 81 coarse- and 334 fine-grained
expression modules, and secondly associates a set of TFs
(among a pool of 580 candidates) to each one of these
modules by defining the expression level of a module as
the weighted linear combination of the associated regula-
tory TFs; the assignment uses a methodology similar to
the Elastic Net [67] or Lasso, but adds penalty functions
during the reconstruction of the network that prioritizes
similarity (at the TF-module association stage) between
cell lines that are closer in the lineage tree.
There is also a relevant need for the development of
methodologies aiming to integrate omics and clinical
data, both as network-based approaches [68,69] and as
both network and data-driven approaches [70]. Overall,
previous examples are just the tip of the iceberg of what
has been developed, and we expect many more novel
developments in the near future.
Conferences, workshop and projects
Scientific meetings on data integration have proliferated in
the last decade either as specialized stand-alone confer-
ences or as part of a larger congress. To our knowledge
the first International Workshop on Data Integration in
the Life Sciences (DILS) took place in Germany in 2004,
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and last year, 2013, it was in Montreal; the Workshop
aims “to foster discussion, exchange, and innovation in
research and development in the areas of data integration
and data management for the life sciences”. This confer-
ence, which has a strong computational background [3],
has consolidated as a major meeting point in data integra-
tion research. Also conferences such as the International
Conference on Systems Biology has established workshops
on integration-related topics such as metadata or data
visualization (ICSB2013). The International Work-Confer-
ence on Bioinformatics and Biomedical Engineering of
2014 (IWBBIO2014) contains a special session devoted to
“integration of data, methods and tools in biosciences”.
Recent one-time events of interest are the session on Data
Integration hosted at BioMedBridges in 2013; the Statisti-
cal Data Integration Challenges in Computational Biology:
Regulatory Networks and Personalized Medicine Work-
shop organized at BIRS [71]; the Workshop in Genomic
Data Integration 2013 [72] located at Imperial College,
The Next NGS Challenge Conference: Data Analysis and
Integration (Valencia, May 2013) and the High-throughput
Omics and Data Integration Workshop in February 2013
from which this supplement originated.
Canvassing the research community - a survey on data
integration
From February to March 2013 we launched a web inquiry
(see Additional file 1), that continued the survey initiated
during the Omics and Data Integration Workshop, where
we investigated major data-integration challenges for
the research community in the field of life sciences. The
results of this analysis are presented in this section.
Survey: dissemination and biases
By conducting a massive emailing effort among many
institutions, the individuals that completed the survey
(n = 125) more than doubled the number of registra-
tions in relation to the workshop. Still, most participants
were from Europe (80.8%) followed by US (5.6%), mostly
from the academic sector (78.4%) and with major exper-
tise in RNA-seq analysis (punctuation: 3/5) Complete
DNA Sequencing (punctuation: 2.74/5). We obtained a
proper balance between senior (37.6%) and junior
(35.2%) researchers, and since the survey was answered
by a limited number of individuals (125) we did not
consider further stratification. Overall, we acknowledge
that the present survey may not represent the views of
the entire research community but it does highlight
relevant questions and provides initial insights into the
opinion of researchers dealing with data integration
issues.
Survey: main results
An objective of the STATegra project (and also relevant
to the wider scientific community) is to identify current
and upcoming needs w.r.t data-analysis thus accelerating
the development of novel integrative approaches. To
investigate this, we included in the survey a question (4)
to identify the major interests in single data types (see
Additional file 1) for which individuals were able to
select more than one answer. The following aspects of
NGS data types caught the largest interest among the
responders to the survey: RNA-seq (66.1%) and com-
plete DNA-sequencing (36.3%). The second place was
for clinical data (37.9%) followed by proteomics (35.5%).
Most individuals were interested in the integrated analy-
sis of multiple data types (72.8%) and this result was
independent of participation in the Workshop in Omics
Data Integration (Table 1) but significantly correlated
with the researcher’s expertise (p-value < 0.01).
We next asked which integration schemes for two or
more datasets were considered most relevant (Figure 2a
upper matrix). We observed that the regulation of gene
expression is a major goal and the integration of RNA-seq
with all other data-types attracts great attention. Notably
integration of clinical data was stated as very important,
and this is relevant since this result does not particularly
associate with the expertise and interests shown in Supp
Table 1 in Additional file 2, but we believe reflects the
continuous growth of translational research even in groups
devoted to basic science. Integration of proteomics and
RNA-seq was considered of high interest, together with a
cluster formed by histone marks, transcription factor bind-
ing and CpG DNA methylation. We also investigated if
these same integration priorities were maintained when
thinking of clinical environments (Figure 2a, lower
matrix). Clinical data and RNA-seq was the most fre-
quently selected combination, also Clinical Data was
highly associated to exome sequencing, complete DNA
sequencing followed by metabolomics, proteomics and
CpG DNA methylation. Not surprisingly co-morbidities
was selected also as a very interesting data type for this
setting.
Finally we observed that integration of same-type data-
sets was also highlighted (Figure 2b). Once more RNA-seq
(14.4% basic science; 5.6% clinical environment) and clini-
cal data (4.0%; 5.6%) were considered relevant (Figure 2c).
Notably, only integration of several RNA-seq datasets is as
highly prioritized as the integration of heterogeneous data
types. Results were similar if the analysis was performed
after stratification by individuals that “participated or did
not participate” in the Workshop (results not shown).
Present tools in omics research After stating the interest
of the research community in data integration we surveyed
their opinion in the availability of appropriate analysis
tools. We designed a set of questions where “5” was asso-
ciated to complete agreement, and “1” to complete dis-
agreement. When considering the analysis of single data
types there was an overall consensus (average score =
4.01) on the availability of proper tools, it was considered
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that most software was mainly available for researchers
with a programming background (3.45). There was no
clear consensus on the availability of user-friendly tools
(2.72) but there was on the necessity of developing novel
analysis tools in the field (4.55). The average opinion when
asked about methods for integrative analysis of multiple
data types was slightly different as there was no clear con-
sensus on the availability of proper tools (2.57). Other
aspects such as exclusivity of tools for programmers
(3.84), existence of user-friendly software (2.21), and need
of new analysis tools (4.72) had similar scores.
Future tools in omics research When asked about what
should be the major focus in the future the only and
almost complete consensus was in the need of developing
novel tools in explorative data analysis (4.45), causal dis-
covery tools (4.50), knowledge-bases (4.29) and tools for
making public data available and properly organized
(4.51). A major requirement was the development of tools
first as user-friendly software (4.60) and secondly as Open-
Source software such as Bioconductor packages (4.16).
Funding and research participants were asked where
funding agencies would be required to invest in order to
Table 1 Scientific interest(s) of survey participants.
ALL Workshop participant Not a participant
Progress in experimental data production methods/technology 25.60% 22.03% 28.79%
Single data-type analysis methods. 29.60% 37.29% 22.73%
Multiple data-type integrated analysis 72.80% 76.27% 69.70%
Biomarker discovery 35.20% 28.81% 40.91%
Understanding of biological mechanisms 56.80% 50.85% 62.12%
Decision support for clinical care 25.60% 16.95% 33.33%
This table summarizes Question 3 results (Select the developments you are more interested in). Survey participants were allowed to select more than one answer.
The percentages of selected questions are shown for all participations and after stratification by their participation in the workshop
Figure 2 Relevance of integration schemes. (a) Each matrix location (i,j) shows the percentage of survey participants that selected as relevant
the integration of data type i and data type j in basic (upper matrix) and clinical (lower matrix) research. (b) shows the percentage of
participants that selected as relevant the integration of the same data type for the data types included in the list.
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support the coming future of omics integrative analysis.
Three questions with a 1 (least interesting) to 4 (most
interesting) answer options were provided. Three fund-
ing goals were indicated as most relevant: large publicly
available data-sets (2.35), large data-sets from cohorts of
selected diseases (2.15) and new tools for data analysis
(1.99). Still many participants indicated that other fund-
ing priorities were required such as education, a more
focused tool development proposal on tools for integra-
tion with clinical data, data curation, and “unification
and standardization of all available omics data bases”.
Data standardization Not included in the questionnaire
design but mentioned by many responders in questions
16 (Describe what you think is the most pressing/urgent/
important research problem w.r.t data-integration) and
17 (Any comment you would like to add?) was that data
standardization is still an open issue. Standardization
requirements were identified as two different but linked
topics: the need to defined standard formats for every
data type - which has been partially successfully managed
by the several normalization efforts (e.g. MIAME), and
the standardization of metadata. We acknowledge that,
despite the enormous effort involved in providing anno-
tated data repositories, the metadata included in many of
them is still not sufficiently consistent or comprehensive
enough to support large data approaches. The editorial
team agrees that resources must be committed to the
developing and continuous support of public data reposi-
tories, while focusing not only in the challenges of storing
the massive data files but also for more efficient annota-
tion of the data involved. We believe that this goal will be
facilitated by journal policies requesting and controlling
submission not only of data but also standardized meta-
data prior to publication.
Open challenges and discussion
Data integration in the life sciences is not a new challenge,
but it is a recurring one that has only recently been
unfolded as a major challenge in part driven by technology
development producing increasing amounts and type of
data. However it is become increasingly clear that to be
able to integrate across different types of is not only an
opportunity but also a competitive advantage within the
biological research community. While the availability of
genomics data is reasonably well provided for by publicly
accessible and well-maintained data repositories (with the
relevant exception of clinical data), there is a need for
improved (and novel) annotation standards and require-
ments in data repositories to enable better integration and
reuse of publically available data.
The data exploitation aspect of data integration is
probably the one that requires most attention, as it
involves (1) the use of prior knowledge - and its efficient
storage, (2) the development of statistical methods to
analyze heterogeneous data sets and (3) the creation of
data explorative tools that incorporate both useful sum-
mary statistics and new visualization tools.
We investigated in a survey with 125 responders what
the most urgent questions of the research community are
regarding data integration. Two relevant observations
stand out: first, the need for user-friendly tools targeting
integration of heterogeneous datasets; and secondly the
relevance of translational medicine, as shown by the inter-
est of incorporating clinical data in most integrative omic
studies.
One aspect that we have not discussed in this editorial
is that efficient data integration in life sciences may
require the creation of novel research profiles. Most
bioinformaticians engaged in the analysis of genomics
data are either “trained computer scientists or statisticians
devoted to biology”, or “trained biologists that were
required to learn the basics of programming in order to
dig deeper into their data”. While both are necessary and
have pushed the field forward, it is increasingly recog-
nized that the growth of computational biology requires
the reformulation of the teaching system and the appear-
ance of new wider syllabuses that cover all aspects of this
interdisciplinary research filed in equivalent detail [73]).
This is a major challenge, to raise a new generation of
computer savvy researchers with a good understanding
of the biology thus enabling development and application
of relevant methods for intergration.
A second aspect we have not discussed is the impact of
BIGdata analytics in the life sciences. The term BIGdata
intuitively describes a situation present in many research
fields: the amount of data generated by instruments is
exploding, and in many cases doubling over short periods
of time. Biology is not an exception: “since 2008, genomics
data is outpacing Moore’s Law by a factor of 4” [74]. This
situation results in the requirement for developing scalable
infrastructures able to manage these quantities of data
while making it available for efficient access and indexing.
But more interestingly, big data have provided new ways
to exploit data in many disciplines, such as economics (see
Data Economy), business (as in Amazon or Google, [75]),
high-energy physics [76] and even biology [77]. The main
summary of BIGdata analysis is that even minor changes
or low-level associations may be uncovered by the use of
(very) large numbers of data points; therefore it remains to
be seen how big data concepts will further reshape data
integration in the life sciences.
A final aspect is that data integration is also seen as a com-
mercial product and well-established companies (such as
Ingenuity or Biomax) are competing with novel companies
(such as Anaxomics or LifeMap) in a rapidly advancing field
where the commercial edge is constantly being updated.
What is evident is that the era we are living in is
nothing else than a paradise for integrative data analysis.
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